PROF Profound Medical Corporation

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May 2020

 

Commission File Number: 001-39032

 

 

PROFOUND MEDICAL CORP.

(Translation of the registrant’s name into English)

 

 

2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  ☐            Form 40-F  ☒

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

 

 

 

 

 

Exhibit		Title
99.1		Press Release, dated May 7, 2020
99.2		Unaudited Interim Condensed Consolidated Financial Statements
99.3		Management’s Discussion and Analysis
99.4		Form 52 – 109F2 – Certification of Interim Filings – CEO
99.5		Form 52 – 109F2 – Certification of Interim Filings – CFO

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

				PROFOUND MEDICAL CORP.
Date: May 7, 2020				By:		/s/ Aaron Davidson
						Name: Aaron Davidson
						Title: Chief Financial Officer